Case Study

Early Champions For Peripheral Vascular Technology


A medtech innovator with a breakthrough interventional treatment for critical limb ischemia (CLI) sought a strategic U.S. market entry.


Partnering with S2N Health, the company implemented a data-driven approach to identify high-potential early adopters.

  • Targeted Market Modeling: RepSignal data, coupled with qualitative and quantitative research, fueled AI-powered, custom analytics to pinpoint ideal early adopter segments.
  • CRM Optimization with RepSignal: Integration with pre-populated targeted customer profiles and identified key hospitals and clinicians.
  • Hyper-Targeted Outreach: Initial sales territories focused on high-opportunity geographies. RepSignal’s “shared patient” insights empowered tailored referrer marketing initiatives.



The combined power of RepSignal,, and S2N Health expertise led to early market success and boosted sales productivity. Streamlined workflows and targeted outreach catalyzed rapid market adoption and data-driven insights empowered sales teams for hyper-focused engagement.